Standardized 6-year financial series for Mirum Pharmaceuticals, Inc., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.
Quarterly coverage: 17 periods · latest quarter FY2025-Q3 · TTM revenue growth 99.2%.
The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.
| Fiscal year | Revenue | Adj. EBITDA | EBIT | Net result | Op. cash flow | Capex | Net debt | Status |
|---|---|---|---|---|---|---|---|---|
| FY2020 | 0 | — | -104M | -103M | -89M | -225K | — | comparative annual fact carried from later 10k · missing adjusted ebitda · missing basic eps · missing cost of revenue · missing diluted eps · missing diluted weighted average shares · missing gross profit · missing interest expense · missing net financial debt · missing research and development · missing sg and a |
| FY2021 | 19M | — | -173M | -84M | -133M | -24K | — | missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing net financial debt · missing research and development |
| FY2022 | 77M | — | -131M | -136M | -120M | -278K | — | missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing net financial debt · missing research and development |
| FY2023 | 186M | — | -109M | -163M | -71M | -109K | — | missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing net financial debt · missing research and development |
| FY2024 | 337M | — | -88M | -88M | 10M | -993K | — | missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing net financial debt · missing research and development |
| FY2025 | 521M | — | -22M | -23M | 56M | -954K | — | missing adjusted ebitda · missing cost of revenue · missing gross profit · missing interest expense · missing net financial debt · missing research and development |
SEC EDGAR companyfacts · XBRL · consolidated_reported
comparative_annual_fact_carried_from_later_10k · missing_adjusted_ebitda · missing_basic_eps · missing_cost_of_revenue · missing_diluted_eps · missing_diluted_weighted_average_shares · missing_gross_profit · missing_interest_expense · missing_net_financial_debt · missing_research_and_development · missing_sg_and_a
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_cost_of_revenue · missing_gross_profit · missing_interest_expense · missing_net_financial_debt · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_cost_of_revenue · missing_gross_profit · missing_interest_expense · missing_net_financial_debt · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_cost_of_revenue · missing_gross_profit · missing_interest_expense · missing_net_financial_debt · missing_research_and_development
Open official source filingSEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_cost_of_revenue · missing_gross_profit · missing_interest_expense · missing_net_financial_debt · missing_research_and_development
SEC EDGAR companyfacts · XBRL · consolidated_reported
missing_adjusted_ebitda · missing_cost_of_revenue · missing_gross_profit · missing_interest_expense · missing_net_financial_debt · missing_research_and_development
Open official source filing